514 Episodes

  1. S11 Ep32: Review Key Genitourinary Cancer Data From the 2024 ESMO Congress With Chandler Park, MD

    Published: 11/6/2024

  2. S11 Ep31: How to Use Toripalimab Plus Chemotherapy in Nasophryngeal Carcinoma: With Tarek Mekhail, MD, MSC, FRCSI, FRCSEd

    Published: 11/4/2024

  3. S11 Ep30: SUNLIGHT QOL Data Show Positive Outcomes With T rifluridine-Tipiracil Plus Bevacizumab in CRC : With Joleen Hubbard, MD

    Published: 10/31/2024

  4. S11 Ep29: Ongoing Research Advances Equity and Precision Oncology Through Tissue-Agnostic Therapies: With Chandler Park, MD, and Vivek Subbiah, MD

    Published: 10/30/2024

  5. S11 Ep28: Liquid Biopsy Ushers in a New Era of NSCLC Biomarker Testing: With David R. Gandara, MD

    Published: 10/28/2024

  6. S11 Ep27: Delve into Recent NCCN Guideline Updates for Hepatobiliary and CRC Management: With Alan P. Venook, MD

    Published: 10/24/2024

  7. S11 Ep26: Phase 1 Trials Provide Oncology Fellows With Valuable Clinical Research Experience: With Samuel A. Kareff, MD, MPH

    Published: 10/21/2024

  8. S11 Ep25: FDA Approval Insights: Denileukin Diftitox in Relapsed/Refractory CTCL

    Published: 10/17/2024

  9. S11 Ep24: How to Apply Research Developments in ALK-Positive NSCLC: With Chandler Park, MD, and Tejas Patil, MD

    Published: 10/16/2024

  10. S11 Ep23: Navigating Myelofibrosis: Updates for Community Hematologist Oncologists

    Published: 10/14/2024

  11. S11 Ep22: FDA Approval Insights: Vorasidenib in IDH1/2+ Grade 2 Astrocytoma and Oligodendroglioma

    Published: 10/10/2024

  12. S11 Ep21: Updated VISION Trial Data Showcase the Efficacy of Tepotinib in MET + NSCLC: With Martin Dietrich, MD

    Published: 10/7/2024

  13. S11 Ep20: FDA Approval Insights: Perioperative Durvalumab for Resectable NSCLC

    Published: 10/3/2024

  14. S11 Ep19: Immunotherapy Advances Expand the SCLC Treatment Paradigm: With Chandler Park, MD, and Tejas Patil, MD

    Published: 10/2/2024

  15. S11 Ep18: Board Review Resources 2024

    Published: 9/30/2024

  16. S11 Ep17: How Luspatercept Could Shake Up MDS Management—With Rory Shallis, MD

    Published: 9/26/2024

  17. S11 Ep16: FDA Approval Insights: Afami-Cel for Pretreated, Unresectable or Metastatic Synovial Sarcoma

    Published: 9/23/2024

  18. S11 Ep15: Thomas and Lukas Highlight Updates in Brain Cancer from the 2024 ASCO Annual Meeting

    Published: 9/19/2024

  19. S11 Ep14: Park and Patil Explore Advances in EGFR + NSCLC From ASCO 2024

    Published: 9/18/2024

  20. S11 Ep13: FDA Approval Insights: Epcoritamab in Relapsed/Refractory Follicular Lymphoma

    Published: 9/16/2024

10 / 26